Hereditary cancer syndromes: Are your patients at risk?
Practice identifying and managing individuals at risk for hereditary cancer syndromes.
Patients at increased risk for a hereditary cancer syndrome may be identified through germline testing or a genomic tumor test. Recognizing a patient’s hereditary risk may impact their treatment options, long-term management approach, risks for certain cancers, and have implications for close family members.
While genetic testing can provide important clinical information for medical decision-making, there are benefits, limitations, and risks. This program focuses on developing skills and knowledge to identify those patients most appropriate for genetic testing, choose the right test, counsel patients and use the results to develop a management plan.
The Wayne State University School of Medicine designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This nursing continuing professional development activity was approved by the Northeast Multistate Division Education Unit, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.